Overview
Elizabeth Prystas is an Oncologist practicing medicine in Salt Lake City, Utah.
Dr. Prystas is highly rated in 3 conditions, according to our data. Her clinical expertise encompasses Breast Cancer, Paget Disease of the Breast, Breast Cancer in Men, and Inflammatory Breast Cancer.
She is actively involved in clinical research, participating in 4 clinical trials.
Specialties
Licenses
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Locations
1950 Circle Of Hope Dr, Salt Lake City, UT 84112
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
4 Clinical Trials
Hematology-Oncology - Nielsen Rehabilitation Hospital
Neeraj Agarwal is an Oncologist practicing medicine in Salt Lake City, Utah. Dr. Agarwal is highly rated in 16 conditions, according to our data. His clinical expertise encompasses Prostate Cancer, Renal Cell Carcinoma (RCC), Familial Prostate Cancer, Orchiectomy, and Tissue Biopsy. Dr. Agarwal is board certified in American Board Of Internal Medicine. Dr. Agarwal is currently accepting new patients.
Hematology-Oncology - Nielsen Rehabilitation Hospital
Ignacio Garrido-Laguna is an Oncologist practicing medicine in Salt Lake City, Utah. Dr. Garrido-Laguna is highly rated in 19 conditions, according to our data. His clinical expertise encompasses Pancreatic Cancer, Colorectal Cancer, Pancreatic Ductal Adenocarcinoma, Pancreatoblastoma, and Pancreatectomy. Dr. Garrido-Laguna is board certified in American Board Of Internal Medicine. Dr. Garrido-Laguna is currently accepting new patients.
University Of Utah Hospital Services
Dr. Pulsipher is currently the Division Chief of the Pediatric Hematology at Intermountain Primary Children's Hospital and Oncology, Director of the Children's and Adolescent Cancer Initiative at Huntsman Cancer Institute and a Presidential Chair in Pediatric Oncology and Hematology at the University of Utah. Dr. Pulsipher is an internationally recognized expert in Bone Marrow Transplantation and Cellular Therapy, having directed the world's largest pediatric transplant research group for more than a decade (Pediatric Transplantation and Cellular Therapy Consortium). He has run more than 20 multicenter trials in the field and is considered and expert in broad areas of transplantation and cellular therapy. Areas of focus have included development of reduced toxicity approaches to transplantation of both malignant and non-malignant disorders with a focus on minimizing short and long-term effects of transplant. For non-malignant disorders he has run national protocols that have improved safety for patients with immunodeficiencies, HLH, and bone marrow failure. For cancer, he has developed techniques allowing identification of patients who can avoid radiation-based treatments for leukemia. This has included a novel approach to safer transplantation of patients using half-matched family donors (haploidentical donors) using a novel form of bone marrow graft engineering called alpha-beta T-cell depletion. His desire to develop safer approaches has become a major focus as he has led major studies in the field of chimeric antigen receptor T-cells (CAR T-cells), a safer approach to cancer cure. Dr. Pulsipher's work in cell therapy helped lead to the FDA approval of the first CART cell treatment, tisagenlecleucel, and he continues to run trials in CAR T, NK, and Viral Specific T-cell therapies. He has open protocols aimed at improving outcomes and his lab efforts are focused on making CAR T-cells that last longer and avoid overcome resistance by cancer cells. Dr. Pulsipher's interests have included ensuring that the families of those undergoing transplantation and cell therapy are psychologically well throughout the process. To help with this, he has run several large trials assessing the safety and Quality of Life of pediatric bone marrow donors and is he currently running a large national trial looking at the psychological well-being of donor and recipient families as they go through the transplant process.For questions regarding Dr. Pulsipher's adult practice at the Huntsman Cancer Institute, or for questions about any of our clinical programs and for assistance identifying the right Hematology specialist for you or your family member, please contact our Clinical Care Specialist/New Patient Coordinator at (801) 587-4652. For questions regarding Dr. Pulsipher's pediatric practice and the Blood and Marrow Transplant Program at Primary Children's Medical Center, please call (801) 662-4830. Dr. Pulsipher is highly rated in 12 conditions, according to our data. His clinical expertise encompasses Acute Lymphoblastic Leukemia (ALL), Graft Versus Host Disease (GvHD), Leukemia, Aplastic Anemia, and Bone Marrow Transplant. Dr. Pulsipher is board certified in American Board Of Pediatrics. Dr. Pulsipher is currently accepting new patients.
Frequently Asked Questions about Dr. Elizabeth M. Prystas
How do I make an appointment with Dr. Elizabeth M. Prystas?
You can book an appointment with Dr. Elizabeth M. Prystas by calling their office at 801-585-0100. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. Elizabeth M. Prystas a top-rated expert for Breast Cancer?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Elizabeth M. Prystas is classified as an Distinguished expert for Breast Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Elizabeth M. Prystas specialize in?
While Dr. Elizabeth M. Prystas is a Oncology, they have specific expertise in Breast Cancer, Paget Disease of the Breast, and Breast Cancer in Men. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Oncology.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Breast CancerDr. Prystas isDistinguished. Learn about Breast Cancer.
- Paget Disease of the BreastDr. Prystas isDistinguished. Learn about Paget Disease of the Breast.
- Advanced
- Breast Cancer in MenDr. Prystas isAdvanced. Learn about Breast Cancer in Men.
- Experienced
- Adult Soft Tissue SarcomaDr. Prystas isExperienced. Learn about Adult Soft Tissue Sarcoma.
- AngiosarcomaDr. Prystas isExperienced. Learn about Angiosarcoma.
- Angiosarcoma of the ScalpDr. Prystas isExperienced. Learn about Angiosarcoma of the Scalp.
- Carcinoid SyndromeDr. Prystas isExperienced. Learn about Carcinoid Syndrome.
- Chromophobe Renal Cell CarcinomaDr. Prystas isExperienced. Learn about Chromophobe Renal Cell Carcinoma.
- Clear Cell SarcomaDr. Prystas isExperienced. Learn about Clear Cell Sarcoma.
- Familial Wilms Tumor 2Dr. Prystas isExperienced. Learn about Familial Wilms Tumor 2.
- Gastroenteropancreatic Neuroendocrine Tumor (GEP-NET)
- Inflammatory Breast CancerDr. Prystas isExperienced. Learn about Inflammatory Breast Cancer.
- LiposarcomaDr. Prystas isExperienced. Learn about Liposarcoma.
- Malignant Mixed Mullerian TumorDr. Prystas isExperienced. Learn about Malignant Mixed Mullerian Tumor.
- Neuroendocrine TumorDr. Prystas isExperienced. Learn about Neuroendocrine Tumor.
- Ovarian CancerDr. Prystas isExperienced. Learn about Ovarian Cancer.
- Ovarian CarcinosarcomaDr. Prystas isExperienced. Learn about Ovarian Carcinosarcoma.
- Renal Cell Carcinoma (RCC)Dr. Prystas isExperienced. Learn about Renal Cell Carcinoma (RCC).
- Sertoli-Leydig Cell TumorDr. Prystas isExperienced. Learn about Sertoli-Leydig Cell Tumor.
- Testicular Yolk Sac TumorDr. Prystas isExperienced. Learn about Testicular Yolk Sac Tumor.
- Virilizing Ovarian TumorDr. Prystas isExperienced. Learn about Virilizing Ovarian Tumor.
- Wilms TumorDr. Prystas isExperienced. Learn about Wilms Tumor.
- WT1-Related Wilms Tumor SyndromesDr. Prystas isExperienced. Learn about WT1-Related Wilms Tumor Syndromes.
